Goldman Sachs seems to be the only major bank implementing a start-to-finish AI-coding tool like Devin, but its competitors ...

Roivant Sciences Ltd. (NASDAQ:ROIV) is one of the best biotech stocks to buy according to billionaire Steve Cohen.

Goldman Sachs is hiring an AI engineer to work at its organization, and no, it isn’t an engineer with AI expertise, but an ...

The number of AI-related jobs has grown in recent years, as more postings for AI engineers, GenAI consultants and other roles ...

"There is no sign of a significant impact on most labor market outcomes," chief economist Jan Hatzius writes. But the shift ...

Nebius Group N.V. (NASDAQ:NBIS) is one of the AI Stocks in the Spotlight Today. On July 14, Goldman Sachs initiated coverage ...

The AI room really has some strong legs as we march through the peak of the summer season. And while investors should always ...

The funding round is likely to value the Bengaluru and San Francisco, California-based firm between $750 million and $800 ...

Devin won’t replace humans at the bank. Argenti advocates for a “hybrid” workforce, so instances of it will be supervised by ...

Despite dire forecasts and corporate hype, artificial intelligence (AI) has yet to deliver the sweeping job losses many ...

Goldman Sachs tests AI agent Devin to automate coding tasks, marking a shift toward a hybrid workforce strategy centered on human-AI collaboration.